Menu Search
Equities

Medtronic PLC

MDT:NYQ

Medtronic PLC

Actions
Health CareMedical Equipment and Services
  • Price (USD)85.75
  • Today's Change-0.46 / -0.53%
  • Shares traded139.00
  • 1 Year change+8.59%
  • Beta0.8360
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform13
Hold15
Sell1
Strong Sell1

Share price forecast in USD

The 28 analysts offering 12 month price targets for Medtronic PLC have a median target of 96.00, with a high estimate of 110.12 and a low estimate of 82.00. The median estimate represents a 11.95% increase from the last price of 85.75.
High28.4%110.12
Med12.0%96.00
Low-4.4%82.00

Dividends in USD

In 2024, Medtronic PLC reported a dividend of 2.76 USD, which represents a 1.47% increase over last year. The 11 analysts covering the company expect dividends of 2.82 USD for the upcoming fiscal year, an increase of 2.28%.
Div growth (TTM)1.47%
More ▼

Earnings history & estimates in USD

On Nov 19, 2024, Medtronic PLC reported 2nd quarter 2025 earnings of 1.26 per share. This result was in line with the consensus of the 28 analysts following the company and exceeded last year's 2nd quarter results by 0.80%.
The next earnings announcement is expected on Feb 18, 2025.
Average growth rate+0.75%
Medtronic PLC reported annual 2024 earnings of 5.20 per share on May 23, 2024.
Average growth rate+3.84%
More ▼

Revenue history & estimates in USD

Medtronic plc had 2nd quarter 2025 revenues of 8.40bn. This bettered the 8.27bn consensus of the 25 analysts covering the company. This was 9.10% above the prior year's 2nd quarter results.
Average growth rate+1.42%
Medtronic plc had revenues for the full year 2024 of 32.36bn. This was 3.64% above the prior year's results.
Average growth rate+2.89%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.